Homoharringtonine
AlkaPlorer ID: AK002931
Synonym: '(-)-Homoharringtonine'
IUPAC Name: 1-O-[(2S,3S,6R)-4-methoxy-16,18-dioxa-10-azapentacyclo[11.7.0.02,6.06,10.015,19]icosa-1(20),4,13,15(19)-tetraen-3-yl] 4-O-methyl (2R)-2-hydroxy-2-(4-hydroxy-4-methylpentyl)butanedioate
Structure
SMILES: COC(=O)C[C@](O)(CCCC(C)(C)O)C(=O)O[C@@H]1C(OC)=C[C@]23CCCN2CCC2=CC4=C(C=C2[C@H]13)OCO4
InChI: InChI=1S/C29H39NO9/c1-27(2,33)8-5-10-29(34,16-23(31)36-4)26(32)39-25-22(35-3)15-28-9-6-11-30(28)12-7-18-13-20-21(38-17-37-20)14-19(18)24(25)28/h13-15,24-25,33-34H,5-12,16-17H2,1-4H3/t24-,25-,28+,29-/m1/s1
InChIKey: HYFHYPWGAURHIV-JFIAXGOJSA-N
Source
| Species | Genus | Family | Order | Class | Phylum | Kingdom | Domain |
|---|---|---|---|---|---|---|---|
| Casearia graveolens | Casearia | Salicaceae | Malpighiales | Magnoliopsida | Streptophyta | Viridiplantae | Eukaryota |
Properties Information
Molecule Weight: 545.6290000000004
TPSA?: 123.99000000000002
MolLogP?: 2.5807
Number of H-Donors: 2
Number of H-Acceptors: 10
RingCount: 5
Activities Information
| Organism | Target Name | Standard Type | Standard Value | Standard Units | doi |
|---|---|---|---|---|---|
| Acinetobacter baumannii | Acinetobacter baumannii | Inhibition | 6.01 | % | 10.6019/CHEMBL4513141 |
| Agrobacterium tumefaciens | Agrobacterium tumefaciens | Inhibition | -79.0 | % | 10.1021/np50024a005 |
| Agrobacterium tumefaciens | Agrobacterium tumefaciens | Inhibition | -72.0 | % | 10.1021/np50024a005 |
| Agrobacterium tumefaciens | Agrobacterium tumefaciens | Inhibition | -64.0 | % | 10.1021/np50024a005 |
| Agrobacterium tumefaciens | Agrobacterium tumefaciens | Inhibition | nan | % | 10.1021/np50024a005 |
| Candida albicans | Candida albicans | Inhibition | 3.16 | % | 10.6019/CHEMBL4513141 |
| Cryptococcus neoformans | Cryptococcus neoformans | Inhibition | 1.94 | % | 10.6019/CHEMBL4513141 |
| Escherichia coli | Escherichia coli | Inhibition | 7.87 | % | 10.6019/CHEMBL4513141 |
| Homo sapiens | 786-0 | GI50 | 893.31 | nM | None |
| Homo sapiens | A204 | IC50 | 4.0 | nM | 10.1016/j.ejmech.2022.114731 |
| Homo sapiens | A498 | GI50 | 39.54 | nM | None |
| Homo sapiens | A549 | Activity | nan | None | 10.1016/j.bmcl.2019.06.049 |
| Homo sapiens | A549 | GI50 | 67.76 | nM | None |
| Homo sapiens | A549 | IC50 | 30.0 | nM | 10.1016/j.bmcl.2008.08.050 |
| Homo sapiens | A549 | IC50 | 31.6 | nM | 10.1021/acs.jnatprod.9b00515 |
| Homo sapiens | Acetylcholinesterase | AC50 | 30000.0 | nM | 10.1038/s41467-023-40064-9 |
| Homo sapiens | ACHN | GI50 | 616.6 | nM | None |
| Homo sapiens | Adenosine A1 receptor | AC50 | 30000.0 | nM | 10.1038/s41467-023-40064-9 |
| Homo sapiens | Alpha-1a adrenergic receptor | AC50 | 30000.0 | nM | 10.1038/s41467-023-40064-9 |
| Homo sapiens | Alpha-2a adrenergic receptor | AC50 | 30000.0 | nM | 10.1038/s41467-023-40064-9 |
| Homo sapiens | Androgen Receptor | AC50 | 30000.0 | nM | 10.1038/s41467-023-40064-9 |
| Homo sapiens | BJ | EC50 | 4.88 | nM | None |
| Homo sapiens | BT-549 | GI50 | 3597.49 | nM | None |
| Homo sapiens | Caco-2 | CC50 | 1720.0 | nM | 10.21203/rs.3.rs-23951/v1 |
| Homo sapiens | CAKI-1 | GI50 | 202.77 | nM | None |
| Homo sapiens | CCRF-CEM | GI50 | 21.53 | nM | None |
| Homo sapiens | COLO 205 | GI50 | 218.27 | nM | None |
| Homo sapiens | Cyclooxygenase-1 | AC50 | 10000.0 | nM | 10.1038/s41467-023-40064-9 |
| Homo sapiens | Cyclooxygenase-1 | AC50 | 30000.0 | nM | 10.1038/s41467-023-40064-9 |
| Homo sapiens | DLD-1 | GI50 | 23.12 | nM | None |
| Homo sapiens | DMS-114 | GI50 | 4.699 | nM | None |
| Homo sapiens | DMS-273 | GI50 | 6.792 | nM | None |
| Homo sapiens | Dopamine D1 receptor | AC50 | 30000.0 | nM | 10.1038/s41467-023-40064-9 |
| Homo sapiens | Dopamine D3 receptor | AC50 | 30000.0 | nM | 10.1038/s41467-023-40064-9 |
| Homo sapiens | Dopamine transporter | AC50 | 30000.0 | nM | 10.1038/s41467-023-40064-9 |
| Homo sapiens | DU-145 | GI50 | 741.31 | nM | None |
| Homo sapiens | EKVX | GI50 | 132.74 | nM | None |
| Homo sapiens | Estrogen receptor alpha | AC50 | 30000.0 | nM | 10.1038/s41467-023-40064-9 |
| Homo sapiens | HCC 2998 | GI50 | 58.34 | nM | None |
| Homo sapiens | HCT-116 | GI50 | 110.41 | nM | None |
| Homo sapiens | HCT-116 | IC50 | 13.0 | nM | 10.1016/j.ejmech.2022.114731 |
| Homo sapiens | HCT-15 | GI50 | 217.27 | nM | None |
| Homo sapiens | HeLa | IC50 | 400.0 | nM | 10.1021/acs.jnatprod.0c01354 |
| Homo sapiens | HeLa | IC50 | 1700.0 | nM | 10.1021/acs.jnatprod.1c00888 |
| Homo sapiens | HeLa | Inhibition | 50.0 | % | 10.1021/acs.jmedchem.7b00315 |
| Homo sapiens | HepG2 | IC50 | 34.5 | nM | 10.1021/acs.jnatprod.9b00515 |
| Homo sapiens | HepG2 | IC50 relative | 200.0 | nM | 10.6019/EOS300108 |
| Homo sapiens | HERG | AC50 | 30000.0 | nM | 10.1038/s41467-023-40064-9 |
| Homo sapiens | Histamine H3 receptor | AC50 | 30000.0 | nM | 10.1038/s41467-023-40064-9 |
| Homo sapiens | Histone deacetylase 6 | Inhibition | -2.3 | % | 10.6019/CHEMBL4808148 |
| Homo sapiens | Histone deacetylase 6 | Inhibition | 28.94 | % | 10.6019/CHEMBL4808148 |
| Homo sapiens | HL-60 | GI50 | 32.51 | nM | None |
| Homo sapiens | HL-60 | IC50 | 13.0 | nM | 10.1016/j.ejmech.2022.114731 |
| Homo sapiens | HL-60 | IC50 | 21.8 | nM | 10.1021/acs.jnatprod.1c00888 |
| Homo sapiens | HL-60 | IC50 | 22.0 | nM | 10.1021/acs.jnatprod.7b00541 |
| Homo sapiens | HL-60 | Ratio IC50 | 125.0 | None | 10.1039/C0MD00241K |
| Homo sapiens | HOP-18 | GI50 | 59.98 | nM | None |
| Homo sapiens | HOP-62 | GI50 | 59.7 | nM | None |
| Homo sapiens | HOP-92 | GI50 | 86.9 | nM | None |
| Homo sapiens | Hs-578T | GI50 | 1066.6 | nM | None |
| Homo sapiens | HT-29 | GI50 | 115.08 | nM | None |
| Homo sapiens | Huh-7 | IC50 | 40.0 | nM | 10.1016/j.ejmech.2022.114731 |
| Homo sapiens | IGROV-1 | GI50 | 128.82 | nM | None |
| Homo sapiens | K562 | GI50 | 39.72 | nM | None |
| Homo sapiens | K562 | IC50 | 0.04389 | ug.mL-1 | 10.1016/j.ejmech.2022.114442 |
| Homo sapiens | K562 | IC50 | 14.0 | nM | 10.1016/j.ejmech.2022.114731 |
| Homo sapiens | KB | ED50 | 3.9 | ug ml-1 | 10.1021/np50022a010 |
| Homo sapiens | KB | IC50 | 4.0 | nM | 10.1016/j.bmcl.2008.08.050 |
| Homo sapiens | KM12 | GI50 | 142.23 | nM | None |
| Homo sapiens | KM-20L2 | GI50 | 19.19 | nM | None |
| Homo sapiens | L02 | IC50 | 64.0 | nM | 10.1016/j.ejmech.2022.114731 |
| Homo sapiens | LOX IMVI | GI50 | 44.36 | nM | None |
| Homo sapiens | M14 | GI50 | 1205.04 | nM | None |
| Homo sapiens | M19-MEL | GI50 | 19.36 | nM | None |
| Homo sapiens | Malme-3M | GI50 | 56.75 | nM | None |
| Homo sapiens | MCF7 | GI50 | 14.96 | nM | None |
| Homo sapiens | MCF7 | IC50 | 0.87 | nM | 10.1021/acs.jmedchem.7b00315 |
| Homo sapiens | MDA-MB-231 | GI50 | 1698.24 | nM | None |
| Homo sapiens | MDA-MB-435 | GI50 | 4456.56 | nM | None |
| Homo sapiens | MDA-MB-453 | IC50 | 21.0 | nM | 10.1016/j.ejmech.2022.114731 |
| Homo sapiens | MDA-N | GI50 | 2415.46 | nM | None |
| Homo sapiens | MOLT-4 | GI50 | 12.33 | nM | None |
| Homo sapiens | MOLT-4 | IC50 | 7.0 | nM | 10.1016/j.ejmech.2022.114731 |
| Homo sapiens | Monoamine oxidase A | AC50 | 30000.0 | nM | 10.1038/s41467-023-40064-9 |
| Homo sapiens | Mu opioid receptor | AC50 | 30000.0 | nM | 10.1038/s41467-023-40064-9 |
| Homo sapiens | Muscarinic acetylcholine receptor M1 | AC50 | 30000.0 | nM | 10.1038/s41467-023-40064-9 |
| Homo sapiens | Muscarinic acetylcholine receptor M2 | AC50 | 30000.0 | nM | 10.1038/s41467-023-40064-9 |
| Homo sapiens | MV4-11 | IC50 | 5.0 | nM | 10.1016/j.ejmech.2022.114731 |
| Homo sapiens | NCI/ADR-RES | GI50 | 3872.58 | nM | None |
| Homo sapiens | NCI-H1299 | IC50 | 22.0 | nM | 10.1016/j.ejmech.2022.114731 |
| Homo sapiens | NCI-H1975 | IC50 | 22.0 | nM | 10.1016/j.ejmech.2022.114731 |
| Homo sapiens | NCI-H226 | GI50 | 89.95 | nM | None |
| Homo sapiens | NCI-H23 | GI50 | 52.84 | nM | None |
| Homo sapiens | NCI-H322M | GI50 | 909.91 | nM | None |
| Homo sapiens | NCI-H460 | GI50 | 13.0 | nM | None |
| Homo sapiens | NCI-H522 | GI50 | 39.63 | nM | None |
| Homo sapiens | NCI-H716 | IC50 | 65.0 | nM | 10.1016/j.ejmech.2022.114731 |
| Homo sapiens | Norepinephrine transporter | AC50 | 30000.0 | nM | 10.1038/s41467-023-40064-9 |
| Homo sapiens | OCI-Ly3 | IC50 | 5.0 | nM | 10.1016/j.ejmech.2022.114731 |
| Homo sapiens | OVCAR-3 | GI50 | 212.32 | nM | None |
| Homo sapiens | OVCAR-4 | GI50 | 341.98 | nM | None |
| Homo sapiens | OVCAR-5 | GI50 | 494.31 | nM | None |
| Homo sapiens | OVCAR-8 | GI50 | 146.22 | nM | None |
| Homo sapiens | Panel NCI-60 (60 carcinoma cell lines) | GI50 | 4.4 | nM | 10.1021/jm049838d |
| Homo sapiens | PC-3 | GI50 | 3013.01 | nM | None |
| Homo sapiens | Phosphodiesterase 3A | AC50 | 30000.0 | nM | 10.1038/s41467-023-40064-9 |
| Homo sapiens | Phosphodiesterase 4A | AC50 | 30000.0 | nM | 10.1038/s41467-023-40064-9 |
| Homo sapiens | Progesterone receptor | AC50 | 30000.0 | nM | 10.1038/s41467-023-40064-9 |
| Homo sapiens | RPMI-8226 | GI50 | 38.82 | nM | None |
| Homo sapiens | RXF 393 | GI50 | 106.66 | nM | None |
| Homo sapiens | Serotonin 1a (5-HT1a) receptor | AC50 | 30000.0 | nM | 10.1038/s41467-023-40064-9 |
| Homo sapiens | Serotonin 2b (5-HT2b) receptor | AC50 | 30000.0 | nM | 10.1038/s41467-023-40064-9 |
| Homo sapiens | Serotonin transporter | AC50 | 30000.0 | nM | 10.1038/s41467-023-40064-9 |
| Homo sapiens | SF-268 | GI50 | 148.59 | nM | None |
| Homo sapiens | SF-295 | GI50 | 151.71 | nM | None |
| Homo sapiens | SF-539 | GI50 | 55.98 | nM | None |
| Homo sapiens | SK-MEL-2 | GI50 | 258.82 | nM | None |
| Homo sapiens | SK-MEL-28 | GI50 | 111.43 | nM | None |
| Homo sapiens | SK-MEL-5 | GI50 | 117.49 | nM | None |
| Homo sapiens | SK-OV-3 | GI50 | 122.18 | nM | None |
| Homo sapiens | SN12C | GI50 | 120.78 | nM | None |
| Homo sapiens | SN12K1 | GI50 | 11.46 | nM | None |
| Homo sapiens | SNB-19 | GI50 | 70.63 | nM | None |
| Homo sapiens | SNB-75 | GI50 | 102.09 | nM | None |
| Homo sapiens | SNB-78 | GI50 | 68.23 | nM | None |
| Homo sapiens | SR | GI50 | 32.66 | nM | None |
| Homo sapiens | SW-620 | GI50 | 68.23 | nM | None |
| Homo sapiens | T47D | GI50 | 382.82 | nM | None |
| Homo sapiens | Thrombin | AC50 | 30000.0 | nM | 10.1038/s41467-023-40064-9 |
| Homo sapiens | Thromboxane A2 receptor | AC50 | 30000.0 | nM | 10.1038/s41467-023-40064-9 |
| Homo sapiens | TK-10 | GI50 | 3741.11 | nM | None |
| Homo sapiens | U-251 | GI50 | 57.15 | nM | None |
| Homo sapiens | U-937 | IC50 | 12.0 | nM | 10.1016/j.ejmech.2022.114731 |
| Homo sapiens | UACC-257 | GI50 | 179.47 | nM | None |
| Homo sapiens | UACC-62 | GI50 | 112.98 | nM | None |
| Homo sapiens | UO-31 | GI50 | 545.76 | nM | None |
| Homo sapiens | XF498 | GI50 | 9.141 | nM | None |
| Human immunodeficiency virus 1 | Human immunodeficiency virus type 1 reverse transcriptase | IC50 | 200.0 | ug.mL-1 | 10.1021/np50073a012 |
| Klebsiella pneumoniae | Klebsiella pneumoniae | Inhibition | 9.21 | % | 10.6019/CHEMBL4513141 |
| Mus musculus | 4T1 | IC50 | 60.0 | nM | 10.1016/j.ejmech.2022.114731 |
| Mus musculus | BaF3 | IC50 | 81.0 | nM | 10.1016/j.ejmech.2022.114731 |
| Mus musculus | L1210 | T/C | 123.0 | % | 10.1021/np8006217 |
| Mus musculus | P388 | GI50 | 3.882 | nM | None |
| Mus musculus | P388 | IC50 | 0.017 | ug.mL-1 | 10.1016/0960-894X(96)00302-2 |
| Mus musculus | P388 | T/C | 238.0 | % | 10.1021/np50024a005 |
| Mus musculus | P388 | T/C | 244.0 | % | 10.1021/np8006217 |
| Mus musculus | P388/ADR | GI50 | 246.6 | nM | None |
| Pseudomonas aeruginosa | Pseudomonas aeruginosa | Inhibition | 11.81 | % | 10.6019/CHEMBL4513141 |
| Rattus norvegicus | GABA receptor alpha-1 subunit | AC50 | 30000.0 | nM | 10.1038/s41467-023-40064-9 |
| Severe acute respiratory syndrome coronavirus 2 | Replicase polyprotein 1ab | Inhibition | 6.843 | % | 10.6019/CHEMBL4495564 |
| Severe acute respiratory syndrome coronavirus 2 | Replicase polyprotein 1ab | Inhibition | 20.63 | % | 10.6019/CHEMBL4495564 |
| Severe acute respiratory syndrome coronavirus 2 | SARS-CoV-2 | EC50 | 60.0 | nM | 10.1021/acs.jmedchem.0c01746 |
| Severe acute respiratory syndrome coronavirus 2 | SARS-CoV-2 | EC50 | 2100.0 | nM | 10.1016/j.bmc.2020.115757 |
| Severe acute respiratory syndrome coronavirus 2 | SARS-CoV-2 | Hit score | 0.04224 | None | 10.1101/2020.04.21.054387 |
| Severe acute respiratory syndrome coronavirus 2 | SARS-CoV-2 | IC50 | 4710.0 | nM | 10.21203/rs.3.rs-23951/v1 |
| Severe acute respiratory syndrome coronavirus 2 | SARS-CoV-2 | IC50 | 19952.62 | nM | 10.6019/CHEMBL4651402 |
| Severe acute respiratory syndrome coronavirus 2 | SARS-CoV-2 | IC50 | 20000.0 | nM | 10.6019/CHEMBL4651402 |
| Severe acute respiratory syndrome coronavirus 2 | SARS-CoV-2 | Inhibition | -0.67 | % | 10.6019/CHEMBL4495565 |
| Severe acute respiratory syndrome coronavirus 2 | SARS-CoV-2 | Inhibition | -0.37 | % | 10.6019/CHEMBL4495565 |
| Severe acute respiratory syndrome coronavirus 2 | SARS-CoV-2 | Inhibition | 102.02 | % | 10.21203/rs.3.rs-23951/v1 |
| Staphylococcus aureus | Staphylococcus aureus | Inhibition | 10.39 | % | 10.6019/CHEMBL4513141 |
| None | ADMET | Selectivity index | 0.0 | None | 10.21203/rs.3.rs-23951/v1 |
| None | Hepatotoxicity | Hepatotoxicity | nan | None | 10.1021/tx900326k |
| None | NON-PROTEIN TARGET | Hepatotoxicity (acute) | 0.0 | % | 10.1016/s0399-8320(04)95062-2 |
| None | NON-PROTEIN TARGET | Hepatotoxicity (animal toxicity known) | nan | None | 10.1016/s0399-8320(04)95062-2 |
| None | NON-PROTEIN TARGET | Hepatotoxicity (benign tumour) | 0.0 | None | 10.1016/s0399-8320(04)95062-2 |
| None | NON-PROTEIN TARGET | Hepatotoxicity (granulomatous hepatitis) | 0.0 | None | 10.1016/s0399-8320(04)95062-2 |
| None | NON-PROTEIN TARGET | Hepatotoxicity (mechanism) | nan | None | 10.1016/s0399-8320(04)95062-2 |
| None | NON-PROTEIN TARGET | Hepatotoxicity (moderate) | 3.0 | None | 10.1016/s0399-8320(04)95062-2 |
| None | NON-PROTEIN TARGET | Hepatotoxicity (moderate) | 15.0 | % | 10.1016/s0399-8320(04)95062-2 |
| None | NON-PROTEIN TARGET | Hepatotoxicity (time to onset) | nan | None | 10.1016/s0399-8320(04)95062-2 |
| None | NON-PROTEIN TARGET | IC50 | 20.0 | nM | 10.1039/C0MD00241K |
| None | NON-PROTEIN TARGET | IC50 | 510.0 | nM | 10.1016/j.bmcl.2008.08.050 |
| None | Unchecked | Activity | nan | None | 10.1016/j.bmcl.2019.06.049 |
| None | Unchecked | EC50 | 100.0 | nM | None |
| None | Unchecked | Hepatotoxicity (acute) | 0.0 | None | 10.1016/s0399-8320(04)95062-2 |
| None | Unchecked | Hepatotoxicity (association with vascular disease) | 0.0 | None | 10.1016/s0399-8320(04)95062-2 |
| None | Unchecked | Hepatotoxicity (choleostasis) | 0.0 | None | 10.1016/s0399-8320(04)95062-2 |
| None | Unchecked | Hepatotoxicity (chronic liver disease) | 0.0 | None | 10.1016/s0399-8320(04)95062-2 |
| None | Unchecked | Hepatotoxicity (cirrhosis) | 0.0 | None | 10.1016/s0399-8320(04)95062-2 |
| None | Unchecked | Hepatotoxicity (comment) | nan | None | 10.1016/s0399-8320(04)95062-2 |
| None | Unchecked | Hepatotoxicity (cytolytic) | 0.0 | None | 10.1016/s0399-8320(04)95062-2 |
| None | Unchecked | Hepatotoxicity (malignant tumour) | 0.0 | None | 10.1016/s0399-8320(04)95062-2 |
| None | Unchecked | Hepatotoxicity (severe hepatitis) | 0.0 | None | 10.1016/s0399-8320(04)95062-2 |
| None | Unchecked | Hepatotoxicity (steatosis) | 0.0 | None | 10.1016/s0399-8320(04)95062-2 |
| None | Unchecked | Hepatotoxicity (successful reintroduction) | nan | None | 10.1016/s0399-8320(04)95062-2 |
| None | Unchecked | IC50 | 18.28 | nM | 10.1016/j.bmcl.2019.06.049 |
| None | Unchecked | IC50 | 1000000.0 | nM | 10.1021/jm00007a003 |
| None | Unchecked | IC50 | 3000000.0 | nM | 10.1021/jm00007a003 |
| None | Unchecked | Inhibition | nan | % | 10.1016/j.bmcl.2019.06.049 |
| None | Unchecked | Kd | 16970.0 | nM | 10.1016/j.bmcl.2019.06.049 |
